Trials / Completed
CompletedNCT06113796
Economic Analysis of Robotic Rectal Resection in German Health Care System
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 65 (actual)
- Sponsor
- Universitätsklinikum Hamburg-Eppendorf · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Analysis of cost effectiveness of robotic rectal resection, either sphincter preserving or abdominoperineal extirpation, in the German diagnosis related groups (DRG) system.
Detailed description
Robotic surgery has many well-known benefits for patients and surgeons, while it comes with higher acquisition and maintenance costs. On the other hand, a higher proportion of minimally invasive procedures can save costs by reducing complications, decreasing hospital stays due to lower morbidity, and saving personnel. To what extent can robotic surgery be cost-covering or even profitable, depending on the postoperative course? This question is investigated under the conditions of the German DRG system.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Surgery | Robotic rectal resection, either sphincter preserving or extirpation |
Timeline
- Start date
- 2018-01-01
- Primary completion
- 2019-12-31
- Completion
- 2021-12-31
- First posted
- 2023-11-02
- Last updated
- 2023-11-02
Locations
1 site across 1 country: Germany
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06113796. Inclusion in this directory is not an endorsement.